Company / Revenue
Cyclerion Therapeutics, Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.1M
FY2025
5-year range
$0 / $2.3M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $297,000 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -14.4%.
Improved from $297,000 to $2M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +91.1%
- 5-Year CAGR
- -14.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.4%, indicating a declining trend.
- Peak revenue was recorded in FY2020.
- Lowest revenue in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1M | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $297.0K | +0.0% |
| FY2022 | $297.0K | -87.1% |
| FY2021 | $2.3M | -49.1% |
| FY2020 | $4.5M | +0.0% |
| FY2019 | $4.5M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026